Efficacy and prognostic factors of COVID‐19 vaccine in patients with hepatocellular carcinoma: Analysis of data from a prospective cohort study

Ähnliche Einträge

• Efficacy and safety of atezolizumab plus bevacizumab in patients with portal hypertension for unresectable hepatocellular carcinoma
  von: Takahiro Kinami, et al.
  Veröffentlicht: (2024)
• A polygenetic risk score combined with environmental factors better predict susceptibility to hepatocellular carcinoma in Chinese population
  von: Yuanlin Zou, et al.
  Veröffentlicht: (2024)
• A clinical‐radiomic‐pathomic model for prognosis prediction in patients with hepatocellular carcinoma after radical resection
  von: Qu Xie, et al.
  Veröffentlicht: (2024)
• Identification of molecular characteristics of hepatocellular carcinoma with microvascular invasion based on deep targeted sequencing
  von: Linlin Zheng, et al.
  Veröffentlicht: (2024)
• Risk factors for lenvatinib‐induced palmar‐plantar erythrodysesthesia syndrome in patients with hepatocellular carcinoma: A retrospective study
  von: Shusuke Uekusa, et al.
  Veröffentlicht: (2024)